KMT2A-MLLT3 AML Masquerading as JMML may Disguise Fatal Leukemia

Ashraf Abdullah Saad1, Ismail Beshlawi1, Mathew Zachariah1

  • 1Pediatric Hematology, Oncology and HSCT Unit, Department of Child Health, Sultan Qaboos University Hospital, Muscat, Oman.

Oman Medical Journal
|November 21, 2019
PubMed
Summary

A rare t(9;11)-positive acute myeloid leukemia/juvenile myelomonocytic leukemia overlap can be fatal. Misdiagnosing this lethal leukemia subtype delayed critical treatment for a young patient, highlighting flaws in current diagnostic approaches.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K